scope, a sequel to my previous post. First of all I will admit that I have no proof for my suspicions. However the points you raise are valid and need to be examined. Here are some ideas.
- Institutions are behind the Vivus price fluctuations.
-Institutions can afford to do this, because if I remember correctly
Vivus' offering price ~ 3 years ago as an IPO was ~ $ 8 - 10, so
they have a profit and thus can afford to sell or simply sell short
and still come out with a profit.
-is it possible that these Institutions are playing a psychological
game? ie, they try and psych out as many buyers as they can and
force them out of their position? This is pure and simple stock
manipulation and has happened before.
-heck,is it possible that in some days they buy and sell to one
another? All you need are two guys!! They may have 2, 3, or 4!!!
I have no problem with all this because I suspect they are not braking any law and even if they did
it would be hard to prove so the point is moot.
I feel sorry for the folks that have lost out so far by buying > 20.
However it is important to remember what I was told once when I was in hot waters because my stock
Had fallen: the guy reminded me that you HAVEN'T actually lost anything UNTIL you've
SOLD the stock.
So I am holding tight and actually entrenching my position by buying more on the way down( if it should get there.
I know that TIME is on MY SIDE!!!
Sooner or later, a) a lot of these guys will want to get back in into a hot stock before it takes off.
b) at the same time the shorts need to cover, and do that BEFORE all the above folks GG get in the stock.
So I am going to sit tight and watch the parade,gg.
I know that the fundies are EXCELLENT.
I can't post that article in Geriatrics because it won't scan well ( I lost the $15 I gave my son to do it; he did it but the result is not good,gg ). Anybody can obtain a copy by eitherwriting to:
Marketing Services,
Advanstar Communications
7500 Old Oak Blvd,
Cleveland, Ohio, 44130
Or, calling
Sharon J.Gellman
Sales Rep.
1-212-951-6642
ask for Geriatrics,Erectile Dysfunction: a practical approach for primary care, by Arthur L.Burnett, MD, Assistant Prof of Urology,Dept of Urology, John Hopkins University,pages 34- 50,Volume 53 No 2,February 1998.
I found some interesting things today on the visual disturbances that occur with Viagra. Made lots of calls.
Many are incomplete because of the weekend and because of President's day many Institutions were closed. However it is fascinating how little is known about PDEs in the retina, even though PDEs are fundamental in the visual process. I will be talking with some more ophthalmologists and PhDs doing molecular bioresearch. Essentially nothing is known about the most important part of the visual process which occurs in the part posterior to the retina, the cones. That's because it is very difficult to isolate
The cones. Most studies have only isolated the rods. So we don't really know if the cones have more than I do PDE ( PDE VI ) and that they don't have the same PDE ( PDE V ) as the penis, and that over stimulation of that part won't result in macular retinal degeneration. We don't know if the retinal cone PDEs isn't inhibited at a lower dose than the penile PDE . One of the retina fellows, doing a retina fellowship, asked me if a retinal ERG ( electroretinogram ) had been done on any of the Viagra patients complaining of visual disturbances/" blue halos'; he said that is the only way to evaluate any retinal damage. I told him,
No that none of the Viagra studies so far had mentioned ERGs; they only did general chemistry profiles.
So all this sounds very interesting. Sounds like the other rush job that was done by another " Blue chip ` company, American Home Products, when "t hey had to rush " through Redux because obesity was a " national emergency" and they totally disregard reports of cardiac valve irregularities, and no echocardiograms were done on any of the patients in their phase III study that complained of chest pain. Pill was approved and all this was found out later by physicians in phase IV.
More as I get the data.
TA |
